|
1.
|
Parkin DM, Whelan SL, Ferlay J, Raymond L
and Young J: Cancer Incidence in Five Continents. Volume VII. IARC
Press; Lyon: 1997
|
|
2.
|
Parkin DM, Pisani P and Ferlay J:
Estimates of the worldwide incidence of 25 major cancers in 1990.
Int J Cancer. 80:827–841. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Lau NC, Lim LP, Weinstein EG and Bartel
DP: An abundant class of tiny RNAs with probable regulatory roles
in Caenorhabditis elegans. Science. 294:858–862. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Lee RC and Ambros V: An extensive class of
small RNAs in Caenorhabditis elegans. Science. 294:862–864.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Ambros V: MicroRNA pathways in flies and
worms: growth, death, fat, stress, and timing. Cell. 113:673–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Esquela-Kerscher A and Slack FJ: Oncomirs
– microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269.
2006.
|
|
9.
|
Kumar MS, Lu J, Mercer KL, Golub TR and
Jacks T: Impaired microRNA processing enhances cellular
transformation and tumorigenesis. Nat Genet. 39:673–677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Petrocca F, Visone R, Onelli MR, et al:
E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest
and apoptosis in gastric cancer. Cancer Cell. 13:272–286. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Takagi T, Iio A, Nakagawa Y, Naoe T,
Tanigawa N and Akao Y: Decreased expression of microRNA-143 and
-145 in human gastric cancers. Oncology. 77:12–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Hu Z, Chen J, Tian T, et al: Genetic
variants of miRNA sequences and non small cell lung cancer
survival. J Clin Invest. 118:2600–2608. 2008.PubMed/NCBI
|
|
13.
|
Tian T, Shu Y, Chen J, et al: A functional
genetic variant in microRNA-196a2 is associated with increased
susceptibility of lung cancer in Chinese. Cancer Epidemiol
Biomarkers Prev. 18:1183–1187. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Jazdzewski K, Murray EL, Franssila K,
Jarzab B, Schoenberg DR and de la Chapelle A: Common SNP in
pre-miR-146a decreases mature miR expression and predisposes to
papillary thyroid carcinoma. Proc Natl Acad Sci USA. 105:7269–7274.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Xu T, Zhu Y, Wei QK, et al: A functional
polymorphism in the miR-146a gene is associated with the risk for
hepatocellular carcinoma. Carcinogenesis. 29:2126–2131. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Hu Z, Liang J, Wang Z, et al: Common
genetic variants in premicroRNAs were associated with increased
risk of breast cancer in Chinese women. Hum Mutat. 30:79–84. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Peng S, Kuang Z, Sheng C, et al:
Association of microRNA-196a-2 gene polymorphism with gastric
cancer risk in a Chinese population. Dig Dis Sci. 55:2288–2293.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Tahara T, Shibata T, Arisawa T, et al: CpG
island promoter methylation (CIHM) status of tumor suppressor genes
correlates with morphological appearances of gastric cancer.
Anticancer Res. 30:239–244. 2010.
|
|
19.
|
Tahara T, Shibata T, Nakamura M, et al:
Association between cyclin D1 polymorphism with CpG island promoter
methylation status of tumor suppressor genes in gastric cancer. Dig
Dis Sci. April 16–2010.(E-pub ahead of print).
|
|
20.
|
Lauren P: The two histological main types
of gastric carcinoma: diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965.PubMed/NCBI
|
|
21.
|
Gotoda T, Yanagisawa A, Sasako M, et al:
Incidence of lymph node metastasis from early gastric cancer:
estimation with a large number of cases at two large centers.
Gastric Cancer. 3:219–225. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Toyota M, Ahuja N, Suzuki H, et al:
Aberrant methylation in gastric cancer associated with the CpG
island methylator phenotype. Cancer Res. 59:5438–5442.
1999.PubMed/NCBI
|
|
23.
|
Kang GH, Shim YH, Jung HY, Kim WH, Ro JY
and Rhyu MG: CpG island methylation in premalignant stages of
gastric carcinoma. Cancer Res. 61:2847–2851. 2001.PubMed/NCBI
|
|
24.
|
Chan AO, Lam SK, Wong BC, et al: Promoter
methylation of E-cadherin gene in gastric mucosa associated with
Helicobacter pylori infection and in gastric cancer. Gut.
52:502–506. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Raveh T and Kimchi A: DAP kinase – a
proapoptotic gene that functions as a tumor suppressor. Exp Cell
Res. 264:185–192. 2001.
|
|
26.
|
Schildhaus HU, Krockel I, Lippert H,
Malfertheiner P, Roessner A and Schneider-Stock R: Promoter
hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in
adenocarcinomas of the esophagus, esophagogastric junction and
proximal stomach. Int J Oncol. 26:1493–1500. 2005.PubMed/NCBI
|
|
27.
|
Waki T, Tamura G, Sato M, Terashima M,
Nishizuka S and Motoyama T: Promoter methylation status of
DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric
epithelia. Cancer Sci. 94:360–364. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH
and Kim JS: Aberrant CpG island hypermethylation of chronic
gastritis, in relation to aging, gender, intestinal metaplasia, and
chronic inflammation. Am J Pathol. 163:1551–1556. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Song SY, Kim S, Kim DS, Son HJ, Rhee JC
and Kim YI: Abnormal expression of E-cadherin in early gastric
carcinoma: its relationship with macroscopic growth patterns and
catenin alpha and beta. J Clin Gastroenterol. 38:252–259. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Namieno T, Koito K, Higashi T, Takahashi
M, Yamashita K and Kondo Y: Assessing the suitability of gastric
carcinoma for limited resection: endoscopic prediction of lymph
node metastases. World J Surg. 22:859–864. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Tahara T, Arisawa T, Shibata T, et al:
Increased number of methylated CpG islands correlates with
Helicobacter pylori infection, histological and serological
severity of chronic gastritis. Eur J Gastroenterol Hepatol.
21:613–619. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Tahara T, Shibata T, Nakamura M, et al:
Increased number of CpG island hypermethylation in tumor suppressor
genes of nonneoplastic gastric mucosa correlates with higher risk
of gastric cancer. Digestion. 82:27–36. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Zhang KL, Sun Y, Li Y, et al: Increased
frequency of CpG island methylator phenotype and CDH1 methylation
in a gastric cancer high-risk region of China. Transl Oncol.
1:28–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Luo D, Zhang B, Lv L, et al: Methylation
of CpG islands of p16 associated with progression of primary
gastric carcinomas. Lab Invest. 86:591–598. 2006.PubMed/NCBI
|
